药品注册申请号:022453
申请类型:NDA (新药申请)
申请人:MEITHEAL
申请人全名:MEITHEAL PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 TOPOTECAN HYDROCHLORIDE TOPOTECAN HYDROCHLORIDE SOLUTION;INTRAVENOUS EQ 4MG BASE/4ML (EQ 1MG BASE/ML) No No AP 2012/12/20 2012/12/20 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2019/06/24 SUPPL-11(补充) Approval Labeling STANDARD
2017/09/20 SUPPL-10(补充) Approval Efficacy STANDARD
2016/11/14 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
2016/01/29 SUPPL-7(补充) Approval Labeling STANDARD
2015/12/21 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
2015/03/30 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
2015/02/23 SUPPL-4(补充) Approval Manufacturing (CMC) STANDARD
2014/09/23 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
2014/02/28 SUPPL-2(补充) Approval Labeling STANDARD
2013/10/03 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
2012/12/20 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:TOPOTECAN HYDROCHLORIDE 剂型/给药途径:SOLUTION;INTRAVENOUS 规格:EQ 4MG BASE/4ML (EQ 1MG BASE/ML) 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
200582 001 NDA TOPOTECAN HYDROCHLORIDE TOPOTECAN HYDROCHLORIDE SOLUTION;INTRAVENOUS EQ 4MG BASE/4ML (EQ 1MG BASE/ML) Prescription Yes Yes AP 2011/02/02 HOSPIRA INC
022453 001 NDA TOPOTECAN HYDROCHLORIDE TOPOTECAN HYDROCHLORIDE SOLUTION;INTRAVENOUS EQ 4MG BASE/4ML (EQ 1MG BASE/ML) Discontinued No No AP 2012/12/20 MEITHEAL
204406 002 ANDA TOPOTECAN HYDROCHLORIDE TOPOTECAN HYDROCHLORIDE SOLUTION;INTRAVENOUS EQ 4MG BASE/4ML (EQ 1MG BASE/ML) Prescription No No AP 2017/07/06 ACCORD HLTHCARE
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database